drugset / Trial / NCT07710703
NWRD09 for Persistent Cervical HPV16 Infection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo controlled study to determine the efficacy and safety of NWRD09 in adult women with persistent cervical HPV16 infection.
Timeline
- Start
- 2026-02-10
- Primary completion
- 2026-11-30
- Completion
- 2027-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NWRD09 | Messenger RNA (mRNA) | — | Intramuscular |
Indications
No indication recorded.